ScreenerHero

SYNACT SynAct Pharma AB

STO · SE · Healthcare · Biotechnology · synactpharma.com
17.22SEK+0.58%Mkt Cap: 92.24M $P/E: —

SynAct Pharma AB, a clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden. The company develops AP1189, a drug candidate in Phase 2 clinical trial fo…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap92.24M USD
Enterprise Value94.07M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-10.60M USD
Revenue/Share—
Last Price17.22 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0008241491
Valuation
P/E (Trailing)—
P/E (Forward)-10.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B5.81
EPS (TTM)-1.97
EPS (Forward)-1.78
52W Range
7.05056% of range25.30
52W High25.30 SEK
52W Low7.050 SEK
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-65.08%
ROA-50.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.31M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-8.80%
Net Debt-1.27M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.01
Current Ratio5.69
Quick Ratio4.94
Book Value/Sh3.07 SEK
Cash/Share0.25 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)34.70 SEK
Upside (mean)+101.5%
Target Range30.00 SEK – 39.40 SEK
30.00+101.5% to mean39.40
# Analysts2
Ownership
Shares Out.56.00M
Float37.83M
Insiders25.30%
Institutions19.40%
Technical
SMA 5018.73 (-8.1%)
SMA 20018.34 (-6.1%)
Beta0.76
S&P 52W Chg14.58%
Avg Vol (30d)156.30K
Avg Vol (10d)90.82K
Technical Indicators
RSI (14)41.4
MACD-0.4292
MACD Signal-0.3861
MACD Hist.-0.0430
BB Upper19.23 SEK
BB Middle17.95 SEK
BB Lower16.68 SEK
BB Width14.19%
ATR (14)0.8873 SEK
Vol Ratio (20d)0.41x